Experimental group:Sacituzumab tirumotecan

2 trials

Sponsors

Dongguan People's Hospital, Jiangxi Cancer Hospital

Conditions

Breast CancerSmall cell lung cancer that has transformed after failure of EGFR-TKI and platinum-based chemotherapy

Phase 2

An exploratory study of Sacituzumab Tirumotecan in the treatment of EGFR-mutated platinum-based chemotherapy-resistant transformed small cell lung cancer

Active, not recruitingChiCTR2500113126

Dongguan People's HospitalSmall cell lung cancer that has transformed after failure of EGFR-TKI and platinum-based chemotherapy

Start: 2025-11-30Updated: 2025-12-01

A single-arm, multicenter, phase II clinical trial on sacituzumab tirumotecan with toripalimab in neoadjuvant therapy for triple-negative breast cancer

Active, not recruitingChiCTR2600116626

Jiangxi Cancer HospitalBreast Cancer

Start: 2026-01-25Updated: 2026-01-27